XL-147

• CAT Number: I005671
• CAS Number: 956958-53-5
• Molecular Formula: C₂₁H₁₆N₆O₂S₂
• Molecular Weight: 448.52
• Purity: ≥95%
• Target: PI3K
• Solubility: DMSO ≥86mg/mL Water <1.2mg/mL Ethanol <1.2mg/mL
• Storage: 3 years -20℃ powder
• IUPAC Name: N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide
• InChI: InChI=1S/C25H25ClN6O4S/c1-25(2,27)24(33)28-15-7-6-8-17(13-15)37(34,35)32-23-22(29-19-9-4-5-10-20(19)30-23)31-21-14-16(36-3)11-12-18(21)26/h4-14H,27H2,1-3H3,(H,28,33)(H,29,31)(H,30,32)
• InChIKey: QINPEPAQOBZPOF-UHFFFAOYSA-N
• SMILES: CC(C)(C(=O)NC1=CC(=CC=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=C(C=CC(=C4)OC)Cl)N

XL-147 (Cat.No:I005671) is a promising chemical compound with significant implications in oncology research. As a selective inhibitor of the PI3K enzyme, XL-147 shows potential in targeting cancer cells and halting their growth. Preclinical studies have demonstrated encouraging results, making XL-147 a compelling candidate for future cancer therapies.

Reference

[1]. Patent No: WO 2012065057 





[2]. Patent No: WO 2012006552